Palvella Therapeutics PVLA
NASDAQ PVLA
$125.05 +1.13 (+0.91%)
As of: Oct 21, 2026 · 11:41 AM EDT

Palvella Therapeutics (PVLA) Total Debt (2013 - 2014)

Updated

Palvella Therapeutics (PVLA) recorded Total Debt of $1.27 million in FY2014, down 23.1% from $1.65 million in FY2013.

Analysis

Palvella Therapeutics (PVLA) Total Debt (2013 - 2014) Analysis & Trends

  • Per Business Quant data, PVLA's Total Debt was $1.65 million in FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 49.04 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 70.82 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 32.35 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 26.25 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 63.19 Bn
10 Palvella Therapeutics 1.80 Bn 1.55 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 1.27 Mn
Sep 30, 2014 3,474.00
Jun 30, 2014 474.00
Dec 31, 2013 1.65 Mn
API Access

Palvella Therapeutics Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=PVLA&period=max&api_key=YOUR_API_KEY